BioAlliance Pharma, an innovative Company dedicated to the development of orphan oncology, announced today that Validive (clonidine Lauriad) received a Fast Track designation from the US Food and Drug Administration (FDA) for the prevention ...
Tags: FDA, BioAlliance Pharma, disease, Validive